BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9292532)

  • 1. Seroreactivity to an envelope protein of human T-cell leukemia/lymphoma virus in patients with CD3- (natural killer) lymphoproliferative disease of granular lymphocytes.
    Loughran TP; Hadlock KG; Yang Q; Perzova R; Zambello R; Semenzato G; Foung SK; Poiesz BJ
    Blood; 1997 Sep; 90(5):1977-81. PubMed ID: 9292532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope mapping of HTLV envelope seroreactivity in LGL leukaemia.
    Loughran TP; Hadlock KG; Perzova R; Gentile TC; Yang Q; Foung SK; Poiesz BJ
    Br J Haematol; 1998 May; 101(2):318-24. PubMed ID: 9609528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delineation of an immunodominant and human T-cell lymphotropic virus (HTLV)-specific epitope within the HTLV-I transmembrane glycoprotein.
    Hadlock KG; Goh CJ; Bradshaw PA; Perkins S; Lo J; Kaplan JE; Khabbaz R; Foung SK
    Blood; 1995 Aug; 86(4):1392-9. PubMed ID: 7632947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of HTLV envelope seroreactivity in large granular lymphocyte leukemia.
    Sokol L; Agrawal D; Loughran TP
    Leuk Res; 2005 Apr; 29(4):381-7. PubMed ID: 15725471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prototypical HTLV-I/II infection is rare in LGL leukemia.
    Loughran TP; Sherman MP; Ruscetti FW; Frey S; Coyle T; Montagna RA; Jones B; Starkebaum G; Poiesz BJ
    Leuk Res; 1994 Jun; 18(6):423-9. PubMed ID: 8207960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serologic and molecular evidence for a possible pathogenetic role of viral infection in CD3-negative natural killer-type lymphoproliferative disease of granular lymphocytes.
    Zambello R; Loughran TP; Trentin L; Pontisso P; Battistella L; Raimondi R; Facco M; Sancetta R; Agostini C; Pizzolo G
    Leukemia; 1995 Jul; 9(7):1207-11. PubMed ID: 7630196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization.
    Tanaka Y; Zeng L; Shiraki H; Shida H; Tozawa H
    J Immunol; 1991 Jul; 147(1):354-60. PubMed ID: 1711082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.
    Ida H; Kurata A; Eguchi K; Kawakami A; Migita K; Fukuda T; Nakamura T; Kusumoto Y; Berzofsky JA; Nagataki S
    J Clin Immunol; 1991 May; 11(3):143-51. PubMed ID: 1890164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II.
    Lal RB; Rudolph DL; Coligan JE; Brodine SK; Roberts CR
    Blood; 1992 Jul; 80(2):544-50. PubMed ID: 1627806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of early human T-cell lymphotropic virus type I antibody patterns during seroconversion among transfusion recipients.
    Manns A; Murphy EL; Wilks R; Haynes G; Figueroa JP; Hanchard B; Barnett M; Drummond J; Waters D; Cerney M
    Blood; 1991 Feb; 77(4):896-905. PubMed ID: 1993227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current concepts: large granular lymphocyte leukemia.
    Lamy T; Loughran TP
    Blood Rev; 1999 Dec; 13(4):230-40. PubMed ID: 10741898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LGL leukemia and HTLV.
    Thomas A; Perzova R; Abbott L; Benz P; Poiesz MJ; Dube S; Loughran T; Ferrer J; Sheremata W; Glaser J; Leon-Ponte M; Poiesz BJ
    AIDS Res Hum Retroviruses; 2010 Jan; 26(1):33-40. PubMed ID: 20047475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large Granular Lymphocyte Leukemia.
    Lamy T; Loughran TP
    Cancer Control; 1998 Jan; 5(1):25-33. PubMed ID: 10761014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
    Mangano AM; Remesar M; del Pozo A; Sen L
    J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
    Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF
    J Immunol; 1989 Feb; 142(3):971-8. PubMed ID: 2563272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of adult T-cell leukemia/lymphoma cells by CD4+ helper T lymphocytes specific for human T-cell leukemia virus type I envelope protein.
    Kobayashi H; Nagato T; Yanai M; Oikawa K; Sato K; Kimura S; Tateno M; Omiya R; Celis E
    Clin Cancer Res; 2004 Oct; 10(20):7053-62. PubMed ID: 15501985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of two enzyme-linked immunosorbent assay tests in relation to western blot in detecting human T-cell lymphotropic virus types I and II infection among HIV-1 infected patients from São Paulo, Brazil.
    Caterino-de-Araujo A; de los Santos-Fortuna E; Meleiro MC; Suleiman J; Calabrò ML; Favero A; De Rossi A; Chieco-Bianchi L
    Diagn Microbiol Infect Dis; 1998 Mar; 30(3):173-82. PubMed ID: 9572023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of human T-cell leukemia/lymphoma virus, type II, in a patient with large granular lymphocyte leukemia.
    Loughran TP; Coyle T; Sherman MP; Starkebaum G; Ehrlich GD; Ruscetti FW; Poiesz BJ
    Blood; 1992 Sep; 80(5):1116-9. PubMed ID: 1355373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased seroreactivity to HERV-K10 peptides in patients with HTLV myelopathy.
    Perzova R; Graziano E; Sanghi S; Welch C; Benz P; Abbott L; Lalone D; Glaser J; Loughran T; Sheremata W; Poiesz BJ
    Virol J; 2013 Dec; 10():360. PubMed ID: 24365054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune recognition of genetically diverse simian T-cell lymphotropic virus type I isolates.
    Lazo A; Bailer RT; Blakeslee JR; Yanagihara R; Stevens VC; Kramer L; Lairmore MD
    Arch Virol; 1995; 140(2):307-23. PubMed ID: 7535998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.